Home Webtool Download Documentation Contact

Targets of perturbagens

Perturbagen ID : CID51613

Perturbagen : (+)-13-ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one oxime acetate (ester); (17alpha)-17-(acetyloxy)-13-ethyl-18,19-dinorpregn-4-en-20-yn-3-one 3-oxime; Centrisa 21; Centrisa 28; Centrisa lo 21; Centrisa lo 28; Cyclen tablets (21 day); Cyclen tablets (28 day); D-13beta-ethyl-17alpha-ethynyl-17beta-acetoxygon-4-en-3-one oxime; Dexnorgestrel acetime; Estarylla; Femynor; Mili; Mono-linyah; Mononessa; Norgestimate; Norgestimate and ethinyl estradiol; Norgestimato; Norgestimatum; Ortho cyclen; Ortho tri cyclen; Ortho tri cyclen lo; Previfem; Previfem (21day); Previfem (28day); Sarensis 21; Sarensis 28; Sprintec; Tri femynor; Tri-cyclen lo (-21 day); Tri-cyclen lo (28 day); Tri-cyclen tablets - 21-day; Tri-cyclen tablets - 28-day; Tri-estarylla; Tri-lena 21; Tri-lena 28; Tri-lena lo 21; Tri-lena lo 28; Tri-linyah; Tri-lo- estarylla; Tri-lo-marzia; Tri-lo-mili; Tri-lo-sprintec; Tri-mili; Tri-previfem; Tri-previfem (21 day); Tri-previfem (28 day); Tri-sprintec; Tricira lo; Trinessa; Trinessa lo

Target	Effect	Reference
AR	1	DrugBank
ESR1	1	DrugBank; CLUE; STITCH
NR1I2	1	DrugBank
PGR	1	DrugBank; CLUE; STITCH
SHBG	2	DrugBank